UK Ethics Accelerator: Coordinating and Mobilising Ethics Research Excellence to Inform Key Challenges in a Pandemic Crisis

  • Funded by UK Research and Innovation (UKRI)
  • Total publications:35 publications

Grant number: AH/V013947/1

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020
    2022
  • Known Financial Commitments (USD)

    $1,534,441.05
  • Funder

    UK Research and Innovation (UKRI)
  • Principal Investigator

    Ilina Singh
  • Research Location

    United Kingdom
  • Lead Research Institution

    University of Oxford
  • Research Priority Alignment

    N/A
  • Research Category

    Research to inform ethical issues

  • Research Subcategory

    Research to inform ethical issues in Research

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The COVID-19 crisis demands that policy-makers, researchers, health and social care workers, and members of the public address unprecedented ethical dilemmas on a daily basis. Resolving these is hard, and it is risky. The complexity and speed of ethical challenges are leading to harms-some inevitable, some avoidable-on a significant scale. The main aim of the Ethics Accelerator (EA) is to harness and mobilise existing UK ethics research expertise to bear on these multiple, ongoing ethical challenges. The EA will rapidly provide evidence, guidance and critical analysis to decision- makers, helping to improve decision-making over the evolving pandemic response. A second aim is to enable systematic public deliberation around key ethical challenges. A third aim is to identify strategies to embed ethics at the core of future epidemic preparedness. The EA will leverage and promote a broad network of UK and international researchers to create flexible Taskforces that deliver rapid guidance and responsive advice to leadership in government, science, medicine, and public health. It will establish virtual fora for public discussion, deliberation and information about arising ethical challenges. In coordinating and focusing existing national investments in ethics research, the EA adds significant value and scales up the potential impacts of ethics research in science, medicine, policy and society. Primary outputs will be rapid research reviews; policy guidance; commissioned research; a broad peer review body; and stakeholder engagements. Main outcomes will be decision-making that is informed by ethics expertise, and is more transparent and accountable, thereby improving public trust.

Publicationslinked via Europe PMC

Last Updated:an hour ago

View all publications at Europe PMC

Providing ethics advice in a pandemic, in theory and in practice: A taxonomy of ethics advice.

The ethics of data self-reporting: important issues and best practices

What makes a health system good? From cost-effectiveness analysis to ethical improvement in health systems.

The harm principle, personal identity and identity-relative paternalism.

Race and resource allocation: an online survey of US and UK adults' attitudes toward COVID-19 ventilator and vaccine distribution.

Is public health just science? Values, politics and varied but collective practices to secure better health with justice.

The legal determinants of health (in)justice.

Affirmative action in healthcare resource allocation: Vaccines, ventilators and race.